Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PINCH - PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC

NCT03829007 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03829007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PINCH - PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
Lead sponsor
Radboud University Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
April 15, 2019
Completion date
December 9, 2021
Enrollment
33 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer